AEZS

Aeterna Zentaris (AEZS)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AEZS

<< Previous 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Next >>

Date	Time	Source	Headline	Symbol	Company
03/03/2008	2:08PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
03/03/2008	6:30AM	PR Newswire (US)	AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights	NASDAQ:AEZS
02/29/2008	12:00PM	PR Newswire (US)	AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs	NASDAQ:AEZS
02/28/2008	4:56PM	PR Newswire (US)	Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008	NASDAQ:AEZS	Aeterna Zentaris Inc
02/19/2008	7:30AM	PR Newswire (US)	AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, Californ	NASDAQ:AEZS	Aeterna Zentaris Inc
02/13/2008	12:00PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
02/13/2008	10:42AM	PR Newswire (US)	WallSt.net (www.WallSt.net) Updates the Investment Community Through All-New Interviews With PSMH, SNTA, and AEZS	NASDAQ:AEZS	Aeterna Zentaris Inc
02/12/2008	7:30AM	PR Newswire (US)	AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial C	NASDAQ:AEZS
02/11/2008	1:33PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Statement of Ownership (SC 13G)	NASDAQ:AEZS	Aeterna Zentaris Inc
12/10/2007	8:21AM	PR Newswire (US)	Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory	NASDAQ:AEZS
12/07/2007	9:24AM	PR Newswire (US)	Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) t	NASDAQ:AEZS
12/04/2007	7:30AM	PR Newswire (US)	AEterna Zentaris to Present at Upcoming BMO Capital Markets Focus on Healthcare Conference and RBC Capital Markets Healthcare Co	NASDAQ:AEZS	Aeterna Zentaris Inc
12/03/2007	7:30AM	PR Newswire (US)	AEterna Zentaris Sells Echelon Biosciences to Frontier Scientific	NASDAQ:AEZS
12/03/2007	7:30AM	PR Newswire (US)	Frontier Scientific Inc. Acquires Echelon Biosciences Inc.	NASDAQ:AEZS	Aeterna Zentaris Inc
11/19/2007	8:47AM	PR Newswire (US)	Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th A	NASDAQ:AEZS
11/14/2007	2:52PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
11/14/2007	7:30AM	PR Newswire (US)	Aeterna Zentaris Announces Completion of Patient Enrollment for Multi-Center Phase 2 Trial with Perifosine in Combination with R	NASDAQ:AEZS	Aeterna Zentaris Inc
11/09/2007	9:45AM	PR Newswire (US)	Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chem	NASDAQ:AEZS
11/08/2007	5:01PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
11/08/2007	4:58PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
11/07/2007	7:00AM	PR Newswire (US)	AEterna Zentaris Reports Third Quarter 2007 Financial and Operating Results	NASDAQ:AEZS
11/05/2007	8:29AM	PR Newswire (US)	Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare S	NASDAQ:AEZS
10/31/2007	7:30AM	PR Newswire (US)	AEterna Zentaris to Announce Third Quarter 2007 Financial and Operating Results on November 7, 2007	NASDAQ:AEZS
10/30/2007	4:59PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
10/30/2007	4:59PM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
10/30/2007	7:30AM	PR Newswire (US)	AEterna Zentaris to Present at Upcoming 18th Annual CIBC World Markets Healthcare Conference and at Acumen BioFin Rodman & Rensh	NASDAQ:AEZS
10/25/2007	4:00PM	PR Newswire (US)	AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Tr	NASDAQ:AEZS
10/03/2007	10:55AM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
10/03/2007	10:55AM	Edgar (US Regulatory)	Aeterna Zentaris Inc. - Report of Foreign Issuer (6-K)	NASDAQ:AEZS	Aeterna Zentaris Inc
10/02/2007	10:52AM	PR Newswire (US)	AEterna Zentaris Announces Outcome of Management's Strategic Review	NASDAQ:AEZS